AvidBiotics

About:

AvidBiotics is a biotherapeutics company deploying a biotechnology-derived technology platform with multiple apps in life sciences.

Website: http://www.avidbiotics.com

Description:

AvidBiotics is a biotherapeutics company deploying a proprietary biotechnology-derived technology platform that has multiple applications in life sciences. The company develops novel, non-antibody proteins used to target bacteria, virus-infected cells, and cancers. Its portfolio of therapeutic protein candidates and protein engineering platforms specifically flags virus-infected or cancerous cells for enhanced destruction by the Natural Killer and T-cells of the potent innate immunity systems and focuses on human therapeutic applications of its technologies that enable physicians to activate the immune system to target and destroy cancer cells infected by viruses with laser precision.

Total Funding Amount:

$3.69M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2004-01-01

Contact Email:

jim(AT)avidbiotics.com

Founders:

David Martin, Jeffery Miller, Jim Knighton

Number of Employees:

11-50

Last Funding Date:

2014-09-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai